These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19080990)

  • 61. A case of mycosis fungoides with large cell transformation associated with infliximab treatment.
    Suga H; Sugaya M; Toyama T; Sumida H; Fujita H; Kogure A; Igarashi A; Sato S
    Acta Derm Venereol; 2014 Mar; 94(2):233-4. PubMed ID: 23975254
    [No Abstract]   [Full Text] [Related]  

  • 62. Adverse drug events in infliximab-treated patients compared with the general and psoriasis populations.
    Menter A; Reich K; Gottlieb AB; Bala M; Li S; Hsu MC; Guzzo C; Diels J; Gelfand JM
    J Drugs Dermatol; 2008 Dec; 7(12):1137-46. PubMed ID: 19137767
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Infliximab-induced lichen planopilaris.
    Fernández-Torres R; Paradela S; Valbuena L; Fonseca E
    Ann Pharmacother; 2010 Sep; 44(9):1501-3. PubMed ID: 20702759
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coexistent psoriasis and lupus erythematosus treated with alefacept.
    Berthelot C; Nash J; Duvic M
    Am J Clin Dermatol; 2007; 8(1):47-50. PubMed ID: 17298107
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of severe refractory psoriasis with infliximab. Clinical outcomes after one year of therapy].
    Mahiques Santos L; Martínez Menchón T; Sánchez Carazo JL; Fortea Baixauli JM
    Med Clin (Barc); 2005 Jun; 125(4):159. PubMed ID: 15989862
    [No Abstract]   [Full Text] [Related]  

  • 66. Complementary data for long-term infliximab use in psoriasis.
    Mansouri B; Menter A
    J Am Acad Dermatol; 2014 Sep; 71(3):591. PubMed ID: 25128111
    [No Abstract]   [Full Text] [Related]  

  • 67. [Blasch-kolinear psoriasis revealed by infliximab therapy].
    Sfia M; Roth-Mall B; Tortel MC; Guillaume JC; Cribier B
    Ann Dermatol Venereol; 2009 Dec; 136(12):898-903. PubMed ID: 20004317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reply to 'complementary data for long-term infliximab use in psoriasis'.
    Luber AJ; Tsui CL; Heinecke GM; Lebwohl MG; Levitt JO
    J Am Acad Dermatol; 2014 Sep; 71(3):591-2. PubMed ID: 25128112
    [No Abstract]   [Full Text] [Related]  

  • 69. [Multiple lesions of focal cutaneous mucinosis: a side-effect of anti-TNF alpha therapy?].
    Duparc A; Gosset P; Lasek A; Modiano P
    Ann Dermatol Venereol; 2010 Feb; 137(2):140-2. PubMed ID: 20171438
    [No Abstract]   [Full Text] [Related]  

  • 70. Clinical experience with infliximab biosimilar in psoriasis.
    Ricceri F; Pescitelli L; Lazzeri L; Prignano F
    Br J Dermatol; 2017 Dec; 177(6):e347-e348. PubMed ID: 28646577
    [No Abstract]   [Full Text] [Related]  

  • 71. Infliximab- and methotrexate-resistant rebound of psoriasis after discontinuation of efalizumab (Raptiva).
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Oct; 155(4):846-7. PubMed ID: 16965444
    [No Abstract]   [Full Text] [Related]  

  • 72. [Current status of the treatment of psoriasis?].
    Touraine R
    Rev Prat; 1974 Apr; 24(23):2141-4, 2147-8. PubMed ID: 4416969
    [No Abstract]   [Full Text] [Related]  

  • 73. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infliximab for the treatment of severe pustular psoriasis.
    Elewski BE
    J Am Acad Dermatol; 2002 Nov; 47(5):796-7. PubMed ID: 12399781
    [No Abstract]   [Full Text] [Related]  

  • 75. Dercum's disease (adiposis dolorosa): a report of improvement with infliximab and methotrexate.
    Singal A; Janiga JJ; Bossenbroek NM; Lim HW
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):717. PubMed ID: 17448013
    [No Abstract]   [Full Text] [Related]  

  • 76. Infliximab in a patient with refractory mucosal aphthosis.
    Jacobi A; Debus D; Schuler G; Hertl M
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):109-10. PubMed ID: 18181985
    [No Abstract]   [Full Text] [Related]  

  • 77. Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports.
    Lu J; Li Y; Yu N; Chen F; Ding Y; Yi X
    J Int Med Res; 2020 Mar; 48(3):300060520912091. PubMed ID: 32216562
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Development of lupus erythematosus during infliximab therapy].
    Gyöngyösi N; Lőrincz K; Kárpáti S; Wikonkál N
    Orv Hetil; 2013 Apr; 154(15):590-8. PubMed ID: 23567877
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efalizumab rebound response to a sequential therapy of infliximab followed by efalizumab.
    Brunasso AM; Delfino C; Massone C
    Dermatology; 2009; 218(1):73-4. PubMed ID: 18841002
    [No Abstract]   [Full Text] [Related]  

  • 80. Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme.
    Arnone M; Carvalho AVE; Takahashí MDF; Bernardo WM
    Rev Assoc Med Bras (1992); 2019 May; 65(4):530-534. PubMed ID: 31066805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.